dr. Da Hae Lee

• Werkt in AZ Herentals sinds 2019
• Contact via de raadpleging inwendige ziekten: t 014 24 64 80

Publicaties

• Raets L, Van Hoorenbeeck K, Maes T, Lee D, De Block C, Dirinck E, Van Pottelbergh I, Wierckx K, Laenen A, Bogaerts A, Mathieu C, Benhalima K. Women With Higher GCT Levels but NGT Have a Similarly High Risk for Glucose Intolerance Postpartum as Women With GDM. J Clin Endocrinol Metab. 2025 Dec 18;111(1):e281-e291. doi: 10.1210/clinem/dgaf275. PMID: 40339132
• Raets L, Van Hoorenbeeck K, Maes T, Lee D, De Block C, Dirinck E, Van Pottelbergh I, Wierckx K, Laenen A, Bogaerts A, Mathieu C, Benhalima K. Women With Higher GCT Levels but NGT Have a Similarly High Risk for Glucose Intolerance Postpartum as Women With GDM. J Clin Endocrinol Metab. 2025 Dec 18;111(1):e281-e291. doi: 10.1210/clinem/dgaf275. PMID: 40339132.
• Geerts I, Beunen K, Peeters M, Wilder NV, Ballaux D, Vanhaverbeke G, Taes Y, Aers XP, Nobels F, Van Huffel L, Marlier J, Lee D, Cuypers J, Preumont V, Siegelaar SE, Painter RC, Laenen A, Gillard P, Mathieu C, Benhalima K. Who Benefits Most from Advanced Hybrid Closed Loop Therapy in Pregnancy Across Different Subgroups: A Secondary Analysis of the Randomized Controlled CRISTAL Trial. Diabetes Technol Ther. 2025 Sep 23. doi: 10.1177/15209156251379505. Epub ahead of print. PMID: 40985127
• Azahaf S, Beunen K, Van Wilder N, Ballaux D, Vanhaverbeke G, Taes Y, Aers XP, Nobels F, Van Huffel L, Marlier J, Lee D, Cuypers J, Preumont V, Siegelaar SE, Painter RC, Laenen A, Gillard P, Mathieu C, Luyten J, Benhalima K. Cost-effectiveness of advanced hybrid closed loop therapy compared to standard insulin therapy for type 1 diabetes in pregnancy: an economic evaluation of the CRISTAL trial. EClinicalMedicine. 2025 Feb 14;81:103106. doi: 10.1016/j.eclinm.2025.103106. PMID: 40034575; PMCID: PMC11874532
• Benhalima K, Beunen K, Van Wilder N, Ballaux D, Vanhaverbeke G, Taes Y, Aers XP, Nobels F, Marlier J, Lee D, Cuypers J, Preumont V, Siegelaar SE, Painter RC, Laenen A, Gillard P, Mathieu C. Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2024 Jun;12(6):390-403. doi: 10.1016/S2213-8587(24)00089-5. Epub 2024 Apr 30.PMID: 38697182 Clinical Trial 
• Benhalima K, Geerts I, Calewaert P, Van Rijsselberghe M, Lee D, Bochanen N, Verstraete S, Buyse L, Lewi L, Caron R, Tency I, Staquet M, Vermeersch P, Wens J. The 2024 Flemish consensus on screening for gestational diabetes mellitus early and later in pregnancy. Acta Clin Belg. 2024 Jun;79(3):217-224. doi: 10.1080/17843286.2024.2384258. Epub 2024 Jul 27.PMID: 39068500 Review 
• Beunen K, Gillard P, Van Wilder N, Ballaux D, Vanhaverbeke G, Taes Y, Aers XP, Nobels F, Van Huffel L, Marlier J, Lee D, Cuypers J, Preumont V, Siegelaar SE, Painter RC, Laenen A, Mathieu C, Benhalima K. Advanced Hybrid Closed-Loop Therapy Compared With Standard Insulin Therapy Intrapartum and Early Postpartum in Women With Type 1 Diabetes: A Secondary Observational Analysis From the CRISTAL Randomized Controlled Trial. Diabetes Care. 2024 Nov 1;47(11):2002-2011. doi: 10.2337/dc24-1320.PMID: 39331059 Clinical Trial